Clover Health Inv Stock Current Asset
| 7QD Stock | 3.21 0.04 1.26% |
CLOVER HEALTH INV fundamentals help investors to digest information that contributes to CLOVER HEALTH's financial success or failures. It also enables traders to predict the movement of CLOVER Stock. The fundamental analysis module provides a way to measure CLOVER HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CLOVER HEALTH stock.
CLOVER |
CLOVER HEALTH INV Company Current Asset Analysis
CLOVER HEALTH's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, CLOVER HEALTH INV has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Healthcare Plans (which currently averages 0.0) industry. The current asset for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
CLOVER Fundamentals
| Return On Equity | -1.1 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | (0.14) % | |||
| Shares Outstanding | 383.55 M | |||
| Shares Owned By Insiders | 13.15 % | |||
| Shares Owned By Institutions | 32.44 % | |||
| Revenue | 3.04 B | |||
| Gross Profit | (189.81 M) | |||
| EBITDA | (437.49 M) | |||
| Book Value Per Share | 0.82 X | |||
| Earnings Per Share | (1.34) X | |||
| Target Price | 9.0 | |||
| Number Of Employees | 680 | |||
| Beta | 1.93 | |||
| Market Capitalization | 548.87 M |
About CLOVER HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CLOVER HEALTH INV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CLOVER HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CLOVER HEALTH INV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CLOVER Stock
CLOVER HEALTH financial ratios help investors to determine whether CLOVER Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CLOVER with respect to the benefits of owning CLOVER HEALTH security.